Revolution Medicines, Inc. (NASDAQ:RVMDW) Stock Short Interest Rises 106.3%

Revolution Medicines, Inc. (NASDAQ:RVMDW) saw a large growth in short interest during the month of October. As of October 15th, there was short interest totaling 1,578 shares, a growth of 106.3% from the September 30th total of 765 shares. Based on an average daily volume of 19,075 shares, the days-to-cover ratio is currently 0.1 days.

Revolution Medicines Trading Up 1.8%

Shares of RVMDW traded up $0.17 during trading hours on Friday, hitting $9.81. 5,614 shares of the stock were exchanged, compared to its average volume of 94,843. The business has a 50-day moving average of $10.69 and a 200-day moving average of $6.63. Revolution Medicines has a fifty-two week low of $0.34 and a fifty-two week high of $13.44.

Revolution Medicines Company Profile

Revolution Medicines, Inc is a clinical-stage biopharmaceutical company focused on developing targeted therapies for patients with cancer. The company’s research is centered on the RAS signaling pathway, which is frequently altered in tumors and has historically been difficult to target with medicines.

Revolution Medicines is developing a pipeline of RAS(ON) inhibitors designed to block active RAS proteins and related signaling. Its investigational programs include daraxonrasib (RMC-6236), an oral, broad-spectrum RAS(ON) inhibitor, as well as mutation-selective candidates such as RMC-9805 for KRAS G12D and RMC-6291 for KRAS G12C.